MK-2461 5 mg | ≥98% LKT Laboratories, Inc. MET, FGFR, PDGFR inhibitor. More Information Supplier Page × MK-2461
MK-2461 1 mg | ≥98% LKT Laboratories, Inc. MET, FGFR, PDGFR inhibitor. More Information Supplier Page × MK-2461
NSC-207895 5 mg | ≥98% LKT Laboratories, Inc. Benzofuroxan derivative; MDMX inhibitor. More Information Supplier Page × NSC-207895
NSC-207895 1 mg | ≥98% LKT Laboratories, Inc. Benzofuroxan derivative; MDMX inhibitor. More Information Supplier Page × NSC-207895
GSK-429286A 5 mg | ≥98% LKT Laboratories, Inc. ROCK1/2 inhibitor, potential RSK and p70S6K inhibitor. More Information Supplier Page × GSK-429286A
GDC-0349 1 mg | ≥98% LKT Laboratories, Inc. mTOR inhibitor. More Information Supplier Page × GDC-0349
BMS-777607 5 mg | ≥98% LKT Laboratories, Inc. MET and Ron inhibitor. More Information Supplier Page × BMS-777607
BMS-777607 1 mg | ≥98% LKT Laboratories, Inc. MET and Ron inhibitor. More Information Supplier Page × BMS-777607
Bromosporine 5 mg | ≥98% LKT Laboratories, Inc. BRD2/4/9 and CECR2 inhibitor. More Information Supplier Page × Bromosporine
